The Critical Importance of Early FRAT® (Folate Receptor Autoantibody Test) Screening
Early FRAT® screening detects folate receptor autoantibodies linked to autism and CFDS, enabling timely treatment to improve cognitive and developmental outcomes.
The early detection of folate receptor autoantibodies is necessary because it can lead to timely diagnosis and appropriate management of conditions associated with these autoantibodies. Folate receptor autoantibodies have been found in Cerebral Folate Deficiency Syndrome, Autism Spectrum Disorders, Schizophrenia, Depression and Neural Tube Defects, among other neurodevelopmental disorders.
FRAT® - developed in the lab of Dr. Edward Quadros at the State University of NY (SUNY Downstate) is the only assay available that can screen for BOTH blocking and binding folate receptor autoantibodies. FRAT®, as published in the New England Journal of Medicine, and used in numerous clinical trials, is the world’s leading diagnostic to detect these specific autoantibodies.
The timely initiation of appropriate treatment, such as alternate reduced folates and/or dietary adjustments, may lead to optimal outcomes and improved overall prognosis for the individual.
As with any medical test, the interpretation of the results and the subsequent treatment plan should be discussed with a qualified healthcare professional.
We continuously research the significance of folate receptor autoantibodies and their implications in various neurodevelopment and neuropsychiatric disorders.
Early FRAT® screening detects folate receptor autoantibodies linked to autism and CFDS, enabling timely treatment to improve cognitive and developmental outcomes.
Learn how FRα autoantibodies impair folate transport across the BBB, causing cerebral folate deficiency and impacting brain development and function.
Phosphorus fuels life and energy. Learn its role in DNA, ATP, health, environmental impact, and why this essential element shapes our future.
Early FRAT® testing detects folate receptor autoantibodies, enabling timely treatment to prevent neurological damage and improve outcomes in autism and related disorders.
Learn about Pathological Demand Avoidance (PDA) in autism—key signs, causes, and practical strategies to support individuals and reduce daily challenges.
Iodine, the violet element, drives thyroid hormones, brain development, and metabolism. Learn why this micronutrient shapes human health worldwide.
New Swedish research reveals why autism diagnoses differ between males and females and how awareness is closing the gender gap in autism spectrum disorder.
A new autism theory links symptoms to brain energy deficits. Discover how impaired glucose metabolism may affect behavior, speech, and sensory processing.
Understand the overlap between autism and migraine, including neuroinflammation, mitochondrial function, and folate transport.
Leucovorin may help ASD with FRAAs by bypassing blocked folate transport to the brain. Learn how folinic acid supports communication and treats cerebral folate deficiency.
Understand the neurological link between autism and migraine through key pathways like neuroinflammation, mitochondrial function and folate transport.
FRAT® test detects folate receptor autoantibodies linked to autism, cerebral folate deficiency, and NTDs—enabling early diagnosis and targeted folinic acid treatment.
Explore how folate receptor alpha autoantibodies (FRAAs) disrupt brain folate transport and contribute to autism spectrum disorder, cerebral folate deficiency, and targeted treatment insights.
FRAT® testing prior to leucovorin therapy ensures accurate diagnosis, personalized dosing, and better outcomes in cerebral folate deficiency and ASD.
Discover why zinc is vital for immunity, growth, fertility, brain health, and enzyme function—and how deficiency affects billions worldwide.
Rising autism prevalence and the FDA approval of leucovorin highlight a targeted metabolic approach for ASD linked to cerebral folate deficiency.
Leucovorin demand is rising in ASD care. Learn why folic acid is not an alternative and may worsen cerebral folate deficiency.